日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Suvemcitug plus chemotherapy in women with platinum-resistant recurrent ovarian cancer: the SCORES randomized, double-blinded, phase 3 trial

Suvemcitug联合化疗治疗铂类耐药复发性卵巢癌:SCORES随机、双盲、3期试验

Yuan, Guangwen; Lou, Ge; Li, Jundong; Xu, Mei; Liu, Xiaowei; Wang, Danbo; Zhang, Keqiang; Zhu, Tao; Li, Xiumin; Huang, Yi; Duan, Wei; Wang, Ke; Zhou, Qi; Li, Guiling; Yang, Chen; Zhang, Jiajing; Sun, Haolin; Tang, Renhong; Li, Qingshui; Wu, Lingying

Methionine intervention induces PD-L1 expression to enhance the immune checkpoint therapy response in MTAP-deleted osteosarcoma

蛋氨酸干预诱导PD-L1表达,从而增强MTAP缺失型骨肉瘤的免疫检查点治疗反应

Haoran Mu ,Qi Zhang ,Dongqing Zuo ,Jinzeng Wang ,Yining Tao ,Zhen Li ,Xin He ,Huanliang Meng ,Hongsheng Wang ,Jiakang Shen ,Mengxiong Sun ,Yafei Jiang ,Weisong Zhao ,Jing Han ,Mengkai Yang ,Zhuoying Wang ,Yu Lv ,Yuqin Yang ,Jing Xu ,Tao Zhang ,Liu Yang ,Jun Lin ,Feng Tang ,Renhong Tang ,Haiyan Hu ,Zhengdong Cai ,Wei Sun ,Yingqi Hua

A retrospective cross-sectional study of FGFR2b alterations in Chinese patients with advanced squamous non-small cell lung cancer: prevalence, programmed death-ligand 1 co-expression patterns, and association with clinical outcomes

一项回顾性横断面研究探讨了中国晚期鳞状非小细胞肺癌患者中FGFR2b基因改变的发生率、程序性死亡配体1(PD-L1)共表达模式及其与临床结局的关系。

Wang, Xiyuan; Chi, Kaiwen; Wang, Haiyue; Sun, Shuguang; Ao, Chunxia; Li, Jiongyan; Ge, Yuanjie; Yang, Chen; Fu, Yayuan; Lin, Dongmei; Tang, Renhong; Sun, Wei

Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19

口服西诺替韦治疗轻度至中度新冠肺炎成人患者

Cao, Bin; Wang, Yeming; Lu, Hongzhou; Huang, Chaolin; Yang, Yumei; Shang, Lianhan; Chen, Zhu; Jiang, Rongmeng; Liu, Yihe; Lin, Ling; Peng, Ping; Wang, Fuxiang; Gong, Fengyun; Hu, Honglin; Cheng, Cong; Yao, Xiangyang; Ye, Xianwei; Zhou, Hourong; Shen, Yinzhong; Liu, Chenfan; Wang, Chunying; Yi, Zhennan; Hu, Bijie; Xu, Jiuyang; Gu, Xiaoying; Shen, Jingshan; Xu, Yechun; Zhang, Leike; Fan, Jia; Tang, Renhong; Wang, Chen

Sublingual Edaravone Dexborneol for the Treatment of Acute Ischemic Stroke: The TASTE-SL Randomized Clinical Trial

舌下含服依达拉奉右冰片醇治疗急性缺血性卒中:TASTE-SL随机临床试验

Fu, Yu; Wang, Anxin; Tang, Renhong; Li, Shuya; Tian, Xue; Xia, Xue; Ren, Jinsheng; Yang, Shibao; Chen, Rong; Zhu, Shunwei; Feng, Xiaofei; Yao, Jinliang; Wei, Yan; Dong, Xueshuang; Ling, Yun; Yi, Fei; Deng, Qian; Guo, Cunju; Sui, Yi; Han, Shugen; Wen, Guoqiang; Li, Chuanling; Dong, Aiqin; Sun, Xin; Wang, Zhimin; Shi, Xueying; Liu, Bo; Fan, Dongsheng

Efficacy and safety of Y-2 sublingual tablet for patients with acute ischaemic stroke: protocol of a phase III randomised double-blind placebo-controlled multicentre trial

Y-2舌下片治疗急性缺血性卒中患者的疗效和安全性:一项III期随机双盲安慰剂对照多中心试验方案

Fu, Yu; Tang, Renhong; Chen, Rong; Wang, Anxin; Ren, Jinsheng; Zhu, Shunwei; Feng, Xiaofei; Fan, Dongsheng

Engineering cytokines for cancer immunotherapy: a systematic review

细胞因子工程在癌症免疫治疗中的应用:系统性综述

Fu, Yong; Tang, Renhong; Zhao, Xiaofeng

A novel form of docetaxel polymeric micelles demonstrates anti-tumor and ascites-inhibitory activities in animal models as monotherapy or in combination with anti-angiogenic agents.

一种新型的多西他赛聚合物胶束在动物模型中表现出抗肿瘤和抑制腹水的活性,可作为单一疗法或与抗血管生成药物联合使用

Guo Leilei, Qin Xiaokang, Xue Liting, Yang Janine Y, Zhang Yumei, Zhu Shunwei, Ye Gang, Tang Renhong, Yang WenQing

Novel compound heterozygous mutations in the CHST6 gene cause macular corneal dystrophy in a Han Chinese family

CHST6基因中新的复合杂合突变导致汉族家族出现黄斑角膜营养不良

Huang, Yanxia; Yuan, Lamei; Cao, Yanna; Tang, Renhong; Xu, Hongbo; Tang, Ziqian; Deng, Hao

The Correlation and Influencing Factors of Crisis Response Ability and Psychological Factors in Patients with Liver Cirrhosis

肝硬化患者危机应对能力与心理因素的相关性及影响因素

Ji, Yanping; Ding, Qingbin; Li, Tingting; Tang, Renhong; Zhang, Jing